{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"activated-pi3k-delta","columns":[{"gene":"","key":"population-89497c1ded3df7235021","label":"Activated PI3K-delta syndrome","mondoId":"MONDO:0018338","onsetQualifier":null,"originColumnKey":"MONDO:0018338/ORPHA:397596","originalViews":[{"key":"MONDO:0018338/ORPHA:397596","label":"Activated PI3K-delta syndrome","scopeLabel":"ORPHA:397596","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0547bbf1f8bb98cead765fb8ea4c154b909ffc613320d77dd2d703b43099d8d6","12da93b5ddf04ed8b7607627219f8c73f4ab68e8d91e0020a6993f50ed55b8d5","16629e7530483764c8deb690d24a30dd2ccd335b805ceb60569b267ab0af18a5","1e35173fc886471a035c146bd1c2634620ba7ff653bf83f0a7e3e3e3542b3d28","2af694910f1574af56a594f262728538f9606d8ff5d5a21f2997e361654d54ed","2afbce1d800dccde4058f619350286492f1f3acb78c7e964e7df4230b5de3264","2dd24cebce15b0cdd70bc3a13e991768cda6886606e7c1505a9b945037c3f648","2fe161f73667918904047ce13cb2fe1537576bea806aa1fa2908b7dc8218dbad","3f6fa0d22cf658f5f1c757a58dabe51b706fb7a858aab3225016951397c3e69a","4d77be6473862e985abc686f8ce90ae1096b14bf467e51321b0929e25d54b1aa","4e688deac74b8794de1fa355b8fc4ff50c6be8e3df9aa90e7a8bbe91150b170f","515253f80cccf9e3efd818c4d4ff5daa2728c2e5d5180df46b3d09bd0c7462e6","5c9036eaf5d165f5e40a65ff2bacdf82575b2466eafa292df9d680ac22ca7b6c","6692a2abab263210335523096d10bc17e2be41aab8b7adf73b86c839f3fe44e6","7ce22066df740a275e67548e25a0450ffe101fb80b1a4726af8ff080861b6fe1","84bf14502ac94df799b4f92478ea21085b22ce68301a6bc58edc055fbc518843","88902cd8bb10ec0fa7b62087e9acfb1c14fb685b13c482e0f337accdb285bf79","8b6146704c3a1573ed6ce1b920e545cb8541ee93a73df6c3e41158bbd60cae64","b717395eda89d84101500b392f3c3596b6816aab60f0abe2327fcb31f1f0925a","ba058ac33492c07e3c90b305c67af3441bd235d8052d62c28b6d5dc80b47b7ee","c9ec33c4da82f1e34fdd126ac13f43f9d0205507c8004e4ed9362ae03a6c9588","cc8eddc5c3cd74f78982ba15112f4e0a077bf6aa545c9fddb5176ca6bb0991bb","d45a55ad0ad5a52e28f2b64bd97ef5dd52be4137e0480ae8b68d2bbe2bd90ee9","df509f8253ad2beadf931715e607975be47e3672388219aec7ad3d3559d07ea6"],"recordQualifiers":{},"scopeLabel":"ORPHA:397596","sourceIds":["ORPHA:397596"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-89497c1ded3df7235021"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002242","HP:0001369","HP:0002960","HP:0002110","HP:0011109","HP:0004313","HP:0010976"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"orphanet":24}},"features":[{"hpoId":"HP:0002242","label":"Abnormal intestine morphology","primary":true},{"hpoId":"HP:0001369","label":"Arthritis","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0002110","label":"Bronchiectasis","primary":true},{"hpoId":"HP:0011109","label":"Chronic sinusitis","primary":true},{"hpoId":"HP:0004313","label":"Decreased circulating immunoglobulin concentration","primary":true},{"hpoId":"HP:0010976","label":"Decreased total B cell count","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0003496","label":"Increased circulating IgM concentration","primary":false},{"hpoId":"HP:0011956","label":"Intestinal lymphoid nodular hyperplasia","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0002665","label":"Lymphoma","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0002090","label":"Pneumonia","primary":false},{"hpoId":"HP:0000403","label":"Recurrent otitis media","primary":false},{"hpoId":"HP:0011110","label":"Recurrent tonsillitis","primary":false},{"hpoId":"HP:0200117","label":"Recurrent upper and lower respiratory tract infections","primary":false},{"hpoId":"HP:0031692","label":"Severe cytomegalovirus infection","primary":false},{"hpoId":"HP:0031693","label":"Severe Epstein Barr virus infection","primary":false},{"hpoId":"HP:0032170","label":"Severe varicella zoster infection","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"Activated PI3K-delta syndrome (also known as APDS) is a disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells (lymphopenia), particularly B cells and T cells. Normally, these cells recognize and attack foreign invaders, such as viruses and bacteria, to prevent infection. The severity of activated PI3K-delta syndrome varies widely. Some people may have multiple, severe infections while others show mild symptoms to none at all.","mondoId":"MONDO:0018338","node":{"canonicalSlug":"activated-pi3k-delta","comparisons":[{"documentSha256":"8ca768f7c117cd58c610345ce2d8e046e7a7709a169365b3e6f09a56714e1734","key":"legacy-activated-pi3k-delta","kind":"legacy","label":"activated PI3K-delta syndrome","memberIds":["MONDO:0014222","MONDO:0014453","MONDO:0018338"],"mondoId":"MONDO:0018338","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/activated-pi3k-delta.8ca768f7c117cd58c610345ce2d8e046e7a7709a169365b3e6f09a56714e1734.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Activated PI3K-delta syndrome is caused by variants (also called mutations) in the PIK3CD gene and the PIK3R1 gene. Activated PI3K-delta syndrome type 1 is caused by variants in the PIK3CD gene, which provides instructions for making a protein called p110 delta (p110δ). Activated PI3K-delta syndrome type 2 is caused by variants in the PIK3R1 gene. This gene provides instructions for making slightly different versions of another protein; the most common version is called p85 alpha (p85α).","Both p110δ and p85α are pieces (subunits) of an enzyme called phosphatidylinositol 3-kinase (PI3K), which turns on signaling pathways within cells. The version of PI3K that contains the p110δ and p85α subunits is called PI3K delta. PI3K delta is found in white blood cells, including B cells and T cells. PI3K-delta signaling is involved in the growth and division (proliferation) of white blood cells, and it helps direct B cells and T cells to mature (differentiate) into different types, each of which has a distinct function in the immune system.","The PIK3CD gene variants that cause activated PI3K-delta syndrome lead to the production of an altered p110δ protein. PIK3R1 gene variants lead to an altered p85α protein, sometimes causing it to be abnormally short. These variants are classified as gain-of-function variants because a PI3K-delta enzyme that contains either of the altered subunits is frequently turned on (overactive).","Studies indicate that overactive PI3K-delta signaling alters the differentiation of B cells and T cells, producing cells that cannot respond to infections and that die earlier than usual. The lack of functioning B cells and T cells makes it difficult for people with activated PI3K-delta syndrome to fight off bacterial and viral infections. Overactive PI3K-delta signaling can also stimulate the abnormal proliferation of white blood cells, leading to lymphadenopathy and nodular lymphoid hyperplasia in some affected individuals. An increase in B cell proliferation in combination with reduced immune system function may contribute to the development of lymphoma in people with activated PI3K-delta syndrome."],"causesUrl":"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Activated PI3K-delta syndrome","paragraphs":["Activated PI3K-delta syndrome (also known as APDS) is a disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells (lymphopenia), particularly B cells and T cells. Normally, these cells recognize and attack foreign invaders, such as viruses and bacteria, to prevent infection. The severity of activated PI3K-delta syndrome varies widely. Some people may have multiple, severe infections while others show mild symptoms to none at all.","Most commonly, people with activated PI3K-delta syndrome develop recurrent infections that begin in childhood, particularly in the lungs, sinuses, and ears. Over time, recurrent respiratory tract infections can lead to a condition called bronchiectasis, which damages the passages leading from the windpipe to the lungs (bronchi) and can cause breathing problems. People with activated PI3K-delta syndrome may also have chronic active viral infections, such as Epstein-Barr virus, herpes simplex virus, or cytomegalovirus infections.","Another possible feature of activated PI3K-delta syndrome is abnormal clumping of white blood cells. These clumps can lead to enlarged lymph nodes (lymphadenopathy) or an enlarged spleen (splenomegaly). The white blood cells can also build up to form solid masses (nodular lymphoid hyperplasia), usually in the moist lining of the airways or intestines. While nodular lymphoid hyperplasia is not cancerous (benign), activated PI3K-delta syndrome increases the risk of developing forms of blood cancer called Hodgkin lymphoma and non-Hodgkin lymphoma.","Some people with activated PI3K-delta syndrome develop autoimmunity, which occurs when the body attacks its own tissues and organs by mistake.","There are two types of activated PI3K-delta syndrome, each with different genetic causes."],"reviewed":"2023-08","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome"},"ownColumnKeys":["population-89497c1ded3df7235021"],"publication":"published","relationships":[{"kind":"parent","label":"agammaglobulinemia","mondoId":"MONDO:0015977","slug":"agammaglobulinemia"},{"kind":"child","label":"immunodeficiency 14","mondoId":"MONDO:0014222","slug":"immunodeficiency-14"},{"kind":"child","label":"immunodeficiency 36 with lymphoproliferation","mondoId":"MONDO:0014453","slug":"immunodeficiency-36-with-lymphoproliferation"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/11983","pageMondoId":"MONDO:0018338","source":"GARD","name":"Activated PI3K-delta syndrome","url":"https://rarediseases.info.nih.gov/diseases/11983","relationToPage":"same-condition","coveredMondoIds":["MONDO:0018338"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-21T15:49:16Z","upstream":"ORPHA:397596","rawAttribution":"ORPHA:397596","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"range","key":"0547bbf1f8bb98cead765fb8ea4c154b909ffc613320d77dd2d703b43099d8d6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002090","is_excluded":false,"label":"Pneumonia","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"12da93b5ddf04ed8b7607627219f8c73f4ab68e8d91e0020a6993f50ed55b8d5","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011109","is_excluded":false,"label":"Chronic sinusitis","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"16629e7530483764c8deb690d24a30dd2ccd335b805ceb60569b267ab0af18a5","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031692","is_excluded":false,"label":"Severe cytomegalovirus infection","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1e35173fc886471a035c146bd1c2634620ba7ff653bf83f0a7e3e3e3542b3d28","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2af694910f1574af56a594f262728538f9606d8ff5d5a21f2997e361654d54ed","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2afbce1d800dccde4058f619350286492f1f3acb78c7e964e7df4230b5de3264","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003496","is_excluded":false,"label":"Increased circulating IgM concentration","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2dd24cebce15b0cdd70bc3a13e991768cda6886606e7c1505a9b945037c3f648","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002242","is_excluded":false,"label":"Abnormal intestine morphology","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2fe161f73667918904047ce13cb2fe1537576bea806aa1fa2908b7dc8218dbad","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004313","is_excluded":false,"label":"Decreased circulating immunoglobulin concentration","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3f6fa0d22cf658f5f1c757a58dabe51b706fb7a858aab3225016951397c3e69a","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d77be6473862e985abc686f8ce90ae1096b14bf467e51321b0929e25d54b1aa","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010976","is_excluded":false,"label":"Decreased total B cell count","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e688deac74b8794de1fa355b8fc4ff50c6be8e3df9aa90e7a8bbe91150b170f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011110","is_excluded":false,"label":"Recurrent tonsillitis","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"515253f80cccf9e3efd818c4d4ff5daa2728c2e5d5180df46b3d09bd0c7462e6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c9036eaf5d165f5e40a65ff2bacdf82575b2466eafa292df9d680ac22ca7b6c","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6692a2abab263210335523096d10bc17e2be41aab8b7adf73b86c839f3fe44e6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0032170","is_excluded":false,"label":"Severe varicella zoster infection","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7ce22066df740a275e67548e25a0450ffe101fb80b1a4726af8ff080861b6fe1","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0200117","is_excluded":false,"label":"Recurrent upper and lower respiratory tract infections","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84bf14502ac94df799b4f92478ea21085b22ce68301a6bc58edc055fbc518843","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031693","is_excluded":false,"label":"Severe Epstein Barr virus infection","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88902cd8bb10ec0fa7b62087e9acfb1c14fb685b13c482e0f337accdb285bf79","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002665","is_excluded":false,"label":"Lymphoma","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b6146704c3a1573ed6ce1b920e545cb8541ee93a73df6c3e41158bbd60cae64","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b717395eda89d84101500b392f3c3596b6816aab60f0abe2327fcb31f1f0925a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002110","is_excluded":false,"label":"Bronchiectasis","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba058ac33492c07e3c90b305c67af3441bd235d8052d62c28b6d5dc80b47b7ee","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9ec33c4da82f1e34fdd126ac13f43f9d0205507c8004e4ed9362ae03a6c9588","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000403","is_excluded":false,"label":"Recurrent otitis media","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc8eddc5c3cd74f78982ba15112f4e0a077bf6aa545c9fddb5176ca6bb0991bb","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011956","is_excluded":false,"label":"Intestinal lymphoid nodular hyperplasia","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d45a55ad0ad5a52e28f2b64bd97ef5dd52be4137e0480ae8b68d2bbe2bd90ee9","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df509f8253ad2beadf931715e607975be47e3672388219aec7ad3d3559d07ea6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:397596","disease_name":"Activated PI3K-delta syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:397596","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11983\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Activated PI3K-delta syndrome (also known as APDS) is a disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells (lymphopenia), particularly B cells and T cells. Normally, these cells recognize and attack foreign invaders, such as viruses and bacteria, to prevent infection. The severity of activated PI3K-delta syndrome varies widely. Some people may have multiple, severe infections while others show mild symptoms to none at all.</p><p>Most commonly, people with activated PI3K-delta syndrome develop recurrent infections that begin in childhood, particularly in the lungs, sinuses, and ears. Over time, recurrent respiratory tract infections can lead to a condition called bronchiectasis, which damages the passages leading from the windpipe to the lungs (bronchi) and can cause breathing problems. People with activated PI3K-delta syndrome may also have chronic active viral infections, such as Epstein-Barr virus, herpes simplex virus, or cytomegalovirus infections.</p><p>Another possible feature of activated PI3K-delta syndrome is abnormal clumping of white blood cells. These clumps can lead to enlarged lymph nodes (lymphadenopathy) or an enlarged spleen (splenomegaly). The white blood cells can also build up to form solid masses (nodular lymphoid hyperplasia), usually in the moist lining of the airways or intestines. While nodular lymphoid hyperplasia is not cancerous (benign), activated PI3K-delta syndrome increases the risk of developing forms of blood cancer called Hodgkin lymphoma and non-Hodgkin lymphoma.</p><p>Some people with activated PI3K-delta syndrome develop autoimmunity, which occurs when the body attacks its own tissues and organs by mistake.</p><p>There are two types of activated PI3K-delta syndrome, each with different genetic causes.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Activated PI3K-delta syndrome is caused by variants (also called mutations) in the PIK3CD gene and the PIK3R1 gene. Activated PI3K-delta syndrome type 1 is caused by variants in the PIK3CD gene, which provides instructions for making a protein called p110 delta (p110δ). Activated PI3K-delta syndrome type 2 is caused by variants in the PIK3R1 gene. This gene provides instructions for making slightly different versions of another protein; the most common version is called p85 alpha (p85α).</p><p>Both p110δ and p85α are pieces (subunits) of an enzyme called phosphatidylinositol 3-kinase (PI3K), which turns on signaling pathways within cells. The version of PI3K that contains the p110δ and p85α subunits is called PI3K delta. PI3K delta is found in white blood cells, including B cells and T cells. PI3K-delta signaling is involved in the growth and division (proliferation) of white blood cells, and it helps direct B cells and T cells to mature (differentiate) into different types, each of which has a distinct function in the immune system.</p><p>The PIK3CD gene variants that cause activated PI3K-delta syndrome lead to the production of an altered p110δ protein. PIK3R1 gene variants lead to an altered p85α protein, sometimes causing it to be abnormally short. These variants are classified as gain-of-function variants because a PI3K-delta enzyme that contains either of the altered subunits is frequently turned on (overactive).</p><p>Studies indicate that overactive PI3K-delta signaling alters the differentiation of B cells and T cells, producing cells that cannot respond to infections and that die earlier than usual. The lack of functioning B cells and T cells makes it difficult for people with activated PI3K-delta syndrome to fight off bacterial and viral infections. Overactive PI3K-delta signaling can also stimulate the abnormal proliferation of white blood cells, leading to lymphadenopathy and nodular lymphoid hyperplasia in some affected individuals. An increase in B cell proliferation in combination with reduced immune system function may contribute to the development of lymphoma in people with activated PI3K-delta syndrome.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"activated-pi3k-delta","sourceDocuments":[{"name":"MedlinePlus: Activated PI3K-delta syndrome","reviewed":"2023-08","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/activated-pi3k-delta-syndrome"},{"name":"GARD: Activated PI3K-delta syndrome","reviewed":null,"source_release":"2026-10-21T15:49:16Z","url":"https://rarediseases.info.nih.gov/diseases/11983"}],"sourceNote":"","synonyms":["APDS","senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation"],"takeawayHtml":"","title":"activated PI3K-delta syndrome"},"schemaVersion":1}
